ArticlePLoS medicine2018

Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults.

Martin R Gaudinski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.